 |
       |
|
|
|||||||||||||
 |
||||||||||||||
r. Chen is a co-founder of KAI Pharmaceuticals, a Skyline portfolio company, where he served in a number of positions, including Senior Director of Technology. He received a BA in Biochemistry from University of California at Berkeley in and a Ph.D. from the Department of Molecular Pharmacology at Stanford University. He received an MBA from Stanford Business School in 2009. 
Home About UsOur TeamOur PortfolioWhat We Look ForContact Us2012 Copyright © Skyline Management LLC
|
|
|
|
|
|||||||||||||
|
||||||||||||||
| HomeAbout UsOur TeamOur PortfolioWhat We Look ForContact Us 2012 Copyright © Skyline Management LLC
|
